98%
921
2 minutes
20
Tobacco black shank, induced by Phytophthora nicotianae, ranks among the most destructive diseases threatening global tobacco production. Biological control constitutes a crucial method for the environmentally friendly management of this disease, with the discovery of biocontrol agents serving as the initial step in this endeavor. The present research seeks to uncover new biocontrol agents and plant growth promoters effective against P. nicotianae. A strain of endophytic actinomycete isolated from tobacco, designated W71, was identified as Streptomyces rochei. This strain exhibited strong IAA production capacity and inhibitory activity against P. nicotianae. In greenhouse trials, S. rochei W71 demonstrated significant plant growth promotion effects, markedly improving agronomic traits, root activity, root morphology indices, and antioxidant enzyme activities of tobacco plants. Field trials conducted at the rosette and prosperously growing stages revealed significant enhancements in several key crop parameters following the application of W71 treatment. These improvements encompassed increased maximum leaf length, maximum leaf width, stem girth, and plant height. Additionally, at harvest, W71 was found to facilitate a remarkable 98.91% boost in yield. In vitro inhibition tests demonstrated potent antagonism: live cells of S. rochei W71 suppressed P. nicotianae growth by 96.84%, outperforming the 70.89% inhibition rate of its cell-free culture filtrate. Greenhouse pot trials yielded an 87.53% disease control efficacy against tobacco black shank, and field trials resulted in a 72.68% control efficacy, indicating satisfactory performance. The study results demonstrate that S. rochei W71 possesses both plant growth-promoting properties and biocontrol capabilities against tobacco black shank, making it a promising candidate for use as a plant growth promoter and biological control agent.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1094/PDIS-02-25-0301-RE | DOI Listing |
Cancer Causes Control
September 2025
Department of Nursing Research, The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, 460 W 10th Ave, Columbus, OH, 43210, USA.
Purpose: Understanding how place of residence affects cancer-related health risks is paramount to addressing health disparities in sexual and gender minority (SGM) cancer survivors. This study examined the associations between urbanicity and other social drivers of health on current tobacco and alcohol use in SGM cancer survivors.
Methods: The OUT: National Cancer Survey Study was a cross-sectional, online survey created by the National LGBT Cancer Network (NLCN) from September 2020 to March 2021, targeting U.
JMIR Cancer
September 2025
Department of Health Outcomes and Biomedical Informatics, University of Florida, 1889 Museum Road, Suite 7000, Gainesville, FL, 32611, United States, 1 352 294-5969.
Background: Disparities in cancer burden between transgender and cisgender individuals remain an underexplored area of research.
Objective: This study aimed to examine the cumulative incidence and associated risk factors for cancer and precancerous conditions among transgender individuals compared with matched cisgender individuals.
Methods: We conducted a retrospective cohort study using patient-level electronic health record (EHR) data from the University of Florida Health Integrated Data Repository between 2012 and 2023.
Laryngoscope
September 2025
Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California, USA.
Objective: To evaluate and quantify the mediation effects of neighborhood socioeconomic status (SES), insurance status, and quality of care on racial disparities in HNC survival.
Methods: Retrospective cohort study of data from the California Cancer Registry dataset linked with discharge records and hospital characteristics from the California Department of Health Care Access and Information. The study cohort included adult patients with HNC diagnosed between January 1, 2010, and December 31, 2019.
Obstet Gynecol
September 2025
Department of Health Promotion and Development, the Department of Human Genetics, the Department of Epidemiology, and the Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, and Magee-Womens Research Institute, Pittsburgh, and the Department of Obstetrics and G
Objective: To evaluate whether chronic stress exposure, measured by allostatic load (a biological measure of chronic stress embodiment, including stressors exacerbated by structural inequities [eg, structural racism]) and patient-reported perceived stress in the first trimester of pregnancy, mediates the association between self-identified race and ethnicity and hypertensive disorders of pregnancy (HDP).
Methods: This was a secondary analysis of data from nuMoM2b (Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be), a large prospective cohort study. We evaluated self-identified race and ethnicity as an independent variable (non-Hispanic Black, Hispanic, Asian, non-Hispanic White), and our outcome of interest was HDP (ie, gestational hypertension, preeclampsia or eclampsia).
BMC Public Health
September 2025
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Introduction: Little cigars and cigarillos (LCCs) pose health risks similar to cigarettes yet remain popular among US young adults (YAs), particularly Black or African American YAs. While previous studies have explored beliefs surrounding LCC prevention and use, no research has yet focused on LCC cessation beliefs.
Aims And Methods: This study examined the beliefs of 134 YAs who currently or formerly used LCC aged 18-29, recruited via Qualtrics panels.